Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

The survival and the long-term trends of patients with gastric cancer in Shanghai, China

Authors: Leizhen Zheng, Chunxiao Wu, Pan Xi, Meiling Zhu, Li Zhang, Siyu Chen, Xiaoping Li, Jianchun Gu, Ying Zheng

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Gastric cancer remains a major health issue and a leading cause of death worldwide. This study presented a long-term survival data of gastric cancer registered in Shanghai of China from 1972–2003, with aims to describe the trends as well as the age, sex, stage and tumor sites specific characteristics.

Methods

The main source of information on cancer cases was the notification card sending to the registry. The residential status of cancer cases was confirmed by home-visits. The methods of follow-up have been a mixture of both active and passive ones.

Results

We observed an increased trend of survival probability during the last decades. Patients diagnosed during 1972–1976 had a 5-years relative survival rate at 12% for males and 11% for females, respectively, which had dramatically increased to 30% for male and 32% for female patients respectively during the period of 2002–2003. Among the patients diagnosed in 2002–2003, the overall survival probability declined with patient’s age at the time of diagnosis. The lowest survival rate was observed among the oldest group, with the median survival time of 0.8 years. Patients diagnosed with stage I had a higher relative survival rate. Patients with cardia cancer had the worst prognosis, with the 5-year relative survival rate of 29%.

Conclusions

The survival probability of patients with gastric cancer in Shanghai has improved significantly during the last decades. Age, stage and site of tumor have an impact on prognosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61 (2): 69-90. 10.3322/caac.20107.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61 (2): 69-90. 10.3322/caac.20107.CrossRefPubMed
2.
go back to reference Fitzsimmons D, Osmond C, George S, Johnson CD: Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951–2000. Br J Surg. 2007, 94 (9): 1162-1171. 10.1002/bjs.5751.CrossRefPubMed Fitzsimmons D, Osmond C, George S, Johnson CD: Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951–2000. Br J Surg. 2007, 94 (9): 1162-1171. 10.1002/bjs.5751.CrossRefPubMed
3.
go back to reference Anderson WF, Camargo MC, Fraumeni JJ, Correa P, Rosenberg PS, Rabkin CS: Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010, 303 (17): 1723-1728. 10.1001/jama.2010.496.CrossRefPubMedPubMedCentral Anderson WF, Camargo MC, Fraumeni JJ, Correa P, Rosenberg PS, Rabkin CS: Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010, 303 (17): 1723-1728. 10.1001/jama.2010.496.CrossRefPubMedPubMedCentral
5.
go back to reference Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 2006, 56 (2): 106-130. 10.3322/canjclin.56.2.106.CrossRefPubMed Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics, 2006. CA Cancer J Clin. 2006, 56 (2): 106-130. 10.3322/canjclin.56.2.106.CrossRefPubMed
6.
go back to reference Ding YB, Xia TS, Wu JD, Chen GY, Wang S, Xia JG: Surgical outcomes for gastric cancer of a single institute in southeast China. Am J Surg. 2012, 203 (2): 217-221. 10.1016/j.amjsurg.2010.10.022.CrossRefPubMed Ding YB, Xia TS, Wu JD, Chen GY, Wang S, Xia JG: Surgical outcomes for gastric cancer of a single institute in southeast China. Am J Surg. 2012, 203 (2): 217-221. 10.1016/j.amjsurg.2010.10.022.CrossRefPubMed
7.
go back to reference Xiang YB, Jin F, Gao YT: Cancer survival in Shanghai, China, 1992–1995. IARC Sci Publ. 2011, 162: 55-68.PubMed Xiang YB, Jin F, Gao YT: Cancer survival in Shanghai, China, 1992–1995. IARC Sci Publ. 2011, 162: 55-68.PubMed
8.
go back to reference Gao Y, Lu W: Cancer incidence, mortality and survival rates in urban Shanghai (1973–2000). 2007, Shanghai: Second Military Medical University Press Gao Y, Lu W: Cancer incidence, mortality and survival rates in urban Shanghai (1973–2000). 2007, Shanghai: Second Military Medical University Press
9.
go back to reference Swaminathan R, Lucas E, Sankaranarayanan R: Cancer survival in Africa, Asia, the Caribbean and Central America: database and attributes. IARC Sci Publ. 2011, 162: 23-31.PubMed Swaminathan R, Lucas E, Sankaranarayanan R: Cancer survival in Africa, Asia, the Caribbean and Central America: database and attributes. IARC Sci Publ. 2011, 162: 23-31.PubMed
10.
go back to reference World Health Organization: 10th revision, Volume 1. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. 1992, Geneva, Switzerland: World Health Organization World Health Organization: 10th revision, Volume 1. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. 1992, Geneva, Switzerland: World Health Organization
11.
go back to reference Bao PP, Lu W, Cui Y, Zheng Y, Gu K, Chen Z, Zheng W, Shu XO: Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study. PLoS One. 2012, 7 (6): e39343-10.1371/journal.pone.0039343.CrossRefPubMedPubMedCentral Bao PP, Lu W, Cui Y, Zheng Y, Gu K, Chen Z, Zheng W, Shu XO: Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study. PLoS One. 2012, 7 (6): e39343-10.1371/journal.pone.0039343.CrossRefPubMedPubMedCentral
12.
go back to reference Wang JM, Xu B, Hsieh CC, Jiang QW: Longitudinal trends of stomach cancer and esophageal cancer in Yangzhong County: a high-incidence rural area of China. Eur J Gastroenterol Hepatol. 2005, 17 (12): 1339-1344. 10.1097/00042737-200512000-00012.CrossRefPubMed Wang JM, Xu B, Hsieh CC, Jiang QW: Longitudinal trends of stomach cancer and esophageal cancer in Yangzhong County: a high-incidence rural area of China. Eur J Gastroenterol Hepatol. 2005, 17 (12): 1339-1344. 10.1097/00042737-200512000-00012.CrossRefPubMed
14.
go back to reference Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D: Eurocare Working Group: survival of cancer patients diagnosed 1990–94–results and commentary. Ann Oncol. 2003, 14 (Suppl 5): v61-v118.CrossRefPubMed Sant M, Aareleid T, Berrino F, Bielska LM, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D: Eurocare Working Group: survival of cancer patients diagnosed 1990–94–results and commentary. Ann Oncol. 2003, 14 (Suppl 5): v61-v118.CrossRefPubMed
15.
go back to reference Brenner H, Francisci S, de Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, Allemani C, Ciccolallo L, Coleman M, Sant M: Long-term survival expectations of cancer patients in Europe in 2000–2002. Eur J Cancer. 2009, 45 (6): 1028-1041. 10.1016/j.ejca.2008.11.005.CrossRefPubMed Brenner H, Francisci S, de Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, Allemani C, Ciccolallo L, Coleman M, Sant M: Long-term survival expectations of cancer patients in Europe in 2000–2002. Eur J Cancer. 2009, 45 (6): 1028-1041. 10.1016/j.ejca.2008.11.005.CrossRefPubMed
16.
go back to reference Brenner H, Gondos A, Arndt V: Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol. 2007, 25 (22): 3274-3280. 10.1200/JCO.2007.11.3431.CrossRefPubMed Brenner H, Gondos A, Arndt V: Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol. 2007, 25 (22): 3274-3280. 10.1200/JCO.2007.11.3431.CrossRefPubMed
17.
go back to reference Tsukuma H, Ajiki W, Ioka A, Oshima A: Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 2006, 36 (9): 602-607. 10.1093/jjco/hyl068.CrossRefPubMed Tsukuma H, Ajiki W, Ioka A, Oshima A: Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 2006, 36 (9): 602-607. 10.1093/jjco/hyl068.CrossRefPubMed
20.
go back to reference Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin. 1996, 46 (1): 5-27. 10.3322/canjclin.46.1.5.CrossRefPubMed Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin. 1996, 46 (1): 5-27. 10.3322/canjclin.46.1.5.CrossRefPubMed
21.
go back to reference Verdecchia A, Guzzinati S, Francisci S, de Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M: Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer. 2009, 45 (6): 1042-1066. 10.1016/j.ejca.2008.11.029.CrossRefPubMed Verdecchia A, Guzzinati S, Francisci S, de Angelis R, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M: Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer. 2009, 45 (6): 1042-1066. 10.1016/j.ejca.2008.11.029.CrossRefPubMed
22.
go back to reference Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF: Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011, 20 (8): 1629-1637. 10.1158/1055-9965.EPI-11-0246.CrossRefPubMedPubMedCentral Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF: Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011, 20 (8): 1629-1637. 10.1158/1055-9965.EPI-11-0246.CrossRefPubMedPubMedCentral
23.
go back to reference Tan YK, Fielding JW: Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol. 2006, 18 (8): 821-829. 10.1097/00042737-200608000-00004.CrossRefPubMed Tan YK, Fielding JW: Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol. 2006, 18 (8): 821-829. 10.1097/00042737-200608000-00004.CrossRefPubMed
24.
go back to reference Schlansky B, Sonnenberg A: Epidemiology of noncardia gastric adenocarcinoma in the United States. Am J Gastroenterol. 2011, 106 (11): 1978-1985. 10.1038/ajg.2011.213.CrossRefPubMed Schlansky B, Sonnenberg A: Epidemiology of noncardia gastric adenocarcinoma in the United States. Am J Gastroenterol. 2011, 106 (11): 1978-1985. 10.1038/ajg.2011.213.CrossRefPubMed
25.
go back to reference Rudiger SJ, Feith M, Werner M, Stein HJ: Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000, 232 (3): 353-361. 10.1097/00000658-200009000-00007.CrossRef Rudiger SJ, Feith M, Werner M, Stein HJ: Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000, 232 (3): 353-361. 10.1097/00000658-200009000-00007.CrossRef
26.
go back to reference Deans C, Yeo MS, Soe MY, Shabbir A, Ti TK, So JB: Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011, 35 (3): 617-624. 10.1007/s00268-010-0935-0.CrossRefPubMed Deans C, Yeo MS, Soe MY, Shabbir A, Ti TK, So JB: Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg. 2011, 35 (3): 617-624. 10.1007/s00268-010-0935-0.CrossRefPubMed
27.
go back to reference Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC: Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg. 2009, 96 (7): 724-733. 10.1002/bjs.6584.CrossRefPubMed Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC: Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg. 2009, 96 (7): 724-733. 10.1002/bjs.6584.CrossRefPubMed
28.
go back to reference Ramos-De LMA, Salgado-Nesme N, Torres-Villalobos G, Medina-Franco H: Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg. 2004, 8 (3): 240-244. 10.1016/j.gassur.2003.12.009.CrossRef Ramos-De LMA, Salgado-Nesme N, Torres-Villalobos G, Medina-Franco H: Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg. 2004, 8 (3): 240-244. 10.1016/j.gassur.2003.12.009.CrossRef
29.
go back to reference Roy P, Piard F, Dusserre-Guion L, Martin L, Michiels-Marzais D, Faivre J: Prognostic comparison of the pathological classifications of gastric cancer: a population-based study. Histopathology. 1998, 33 (4): 304-310. 10.1046/j.1365-2559.1998.00534.x.CrossRefPubMed Roy P, Piard F, Dusserre-Guion L, Martin L, Michiels-Marzais D, Faivre J: Prognostic comparison of the pathological classifications of gastric cancer: a population-based study. Histopathology. 1998, 33 (4): 304-310. 10.1046/j.1365-2559.1998.00534.x.CrossRefPubMed
30.
go back to reference Micheli A, Berrino F, Paci E, Verdecchia A, Pierottis MA: Strategies for cancer control in Italy. Tumori. 2007, 93 (4): 329-336.PubMed Micheli A, Berrino F, Paci E, Verdecchia A, Pierottis MA: Strategies for cancer control in Italy. Tumori. 2007, 93 (4): 329-336.PubMed
31.
go back to reference Micheli A, Capocaccia R, Martinez C, Mugno E, Coebergh JW, Baili P, Verdecchia A, Berrino F, Coleman M: Cancer control in Europe: a proposed set of European cancer health indicators. Eur J Public Health. 2003, 13 (3 Suppl): 116-118.CrossRefPubMed Micheli A, Capocaccia R, Martinez C, Mugno E, Coebergh JW, Baili P, Verdecchia A, Berrino F, Coleman M: Cancer control in Europe: a proposed set of European cancer health indicators. Eur J Public Health. 2003, 13 (3 Suppl): 116-118.CrossRefPubMed
32.
go back to reference Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, Capocaccia R: Comparative cancer survival information in Europe. Eur J Cancer. 2009, 45 (6): 901-908. 10.1016/j.ejca.2009.01.018.CrossRefPubMed Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, Capocaccia R: Comparative cancer survival information in Europe. Eur J Cancer. 2009, 45 (6): 901-908. 10.1016/j.ejca.2009.01.018.CrossRefPubMed
33.
go back to reference Perme MP, Stare J, Esteve J: On estimation in relative survival. Biometrics. 2012, 68 (1): 113-120. 10.1111/j.1541-0420.2011.01640.x.CrossRefPubMed Perme MP, Stare J, Esteve J: On estimation in relative survival. Biometrics. 2012, 68 (1): 113-120. 10.1111/j.1541-0420.2011.01640.x.CrossRefPubMed
Metadata
Title
The survival and the long-term trends of patients with gastric cancer in Shanghai, China
Authors
Leizhen Zheng
Chunxiao Wu
Pan Xi
Meiling Zhu
Li Zhang
Siyu Chen
Xiaoping Li
Jianchun Gu
Ying Zheng
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-300

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine